FMRFamide increases the adenylate cyclase activity and cyclic AMP level of molluscan heart

William Joseph Higgins, David A. Price, Michael J. Greenberg

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

FMRFamide (phenylalanyl-methionyl-arginyl-phenylalanine amide) is a cardioexcitatory peptide recently isolated and identified in molluscan ganglia. Both FMRFamide and 5-hydroxytryptamine (5HT), the cardioexcitatory neurotransmitter in molluscs, were tested on the ventricle of the bivalve Mercenaria mercenaria. Both agents increased myocardial contractility, the intracellular cyclic AMP concentration of intact hearts and the adenylate cyclase activity of a myocardial membrane fraction. FMRFamide was 5-10 times more potent than 5HT. All of the effects of 5HT, and none of those of FMRFamide, were blocked by methysergide, a specific 5HT antagonist.

Original languageEnglish (US)
Pages (from-to)425-430
Number of pages6
JournalEuropean Journal of Pharmacology
Volume48
Issue number4
DOIs
StatePublished - Apr 15 1978

Fingerprint

FMRFamide
Adenylyl Cyclases
Cyclic AMP
Mercenaria
Serotonin
phenylalanyl-arginyl-phenylalanine
Methysergide
Serotonin Antagonists
Mollusca
Bivalvia
Ganglia
Neurotransmitter Agents
Peptides
Membranes

Keywords

  • 5-Hydroxytryptamine
  • Adenylate cyclase
  • Cyclic AMP in muscle
  • FMRFamide
  • Methysergide
  • Molluscan heart

ASJC Scopus subject areas

  • Pharmacology

Cite this

FMRFamide increases the adenylate cyclase activity and cyclic AMP level of molluscan heart. / Higgins, William Joseph; Price, David A.; Greenberg, Michael J.

In: European Journal of Pharmacology, Vol. 48, No. 4, 15.04.1978, p. 425-430.

Research output: Contribution to journalArticle

Higgins, William Joseph ; Price, David A. ; Greenberg, Michael J. / FMRFamide increases the adenylate cyclase activity and cyclic AMP level of molluscan heart. In: European Journal of Pharmacology. 1978 ; Vol. 48, No. 4. pp. 425-430.
@article{3ba7a7379be44fceaa030e14bb5a41dd,
title = "FMRFamide increases the adenylate cyclase activity and cyclic AMP level of molluscan heart",
abstract = "FMRFamide (phenylalanyl-methionyl-arginyl-phenylalanine amide) is a cardioexcitatory peptide recently isolated and identified in molluscan ganglia. Both FMRFamide and 5-hydroxytryptamine (5HT), the cardioexcitatory neurotransmitter in molluscs, were tested on the ventricle of the bivalve Mercenaria mercenaria. Both agents increased myocardial contractility, the intracellular cyclic AMP concentration of intact hearts and the adenylate cyclase activity of a myocardial membrane fraction. FMRFamide was 5-10 times more potent than 5HT. All of the effects of 5HT, and none of those of FMRFamide, were blocked by methysergide, a specific 5HT antagonist.",
keywords = "5-Hydroxytryptamine, Adenylate cyclase, Cyclic AMP in muscle, FMRFamide, Methysergide, Molluscan heart",
author = "Higgins, {William Joseph} and Price, {David A.} and Greenberg, {Michael J.}",
year = "1978",
month = "4",
day = "15",
doi = "10.1016/0014-2999(78)90170-X",
language = "English (US)",
volume = "48",
pages = "425--430",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - FMRFamide increases the adenylate cyclase activity and cyclic AMP level of molluscan heart

AU - Higgins, William Joseph

AU - Price, David A.

AU - Greenberg, Michael J.

PY - 1978/4/15

Y1 - 1978/4/15

N2 - FMRFamide (phenylalanyl-methionyl-arginyl-phenylalanine amide) is a cardioexcitatory peptide recently isolated and identified in molluscan ganglia. Both FMRFamide and 5-hydroxytryptamine (5HT), the cardioexcitatory neurotransmitter in molluscs, were tested on the ventricle of the bivalve Mercenaria mercenaria. Both agents increased myocardial contractility, the intracellular cyclic AMP concentration of intact hearts and the adenylate cyclase activity of a myocardial membrane fraction. FMRFamide was 5-10 times more potent than 5HT. All of the effects of 5HT, and none of those of FMRFamide, were blocked by methysergide, a specific 5HT antagonist.

AB - FMRFamide (phenylalanyl-methionyl-arginyl-phenylalanine amide) is a cardioexcitatory peptide recently isolated and identified in molluscan ganglia. Both FMRFamide and 5-hydroxytryptamine (5HT), the cardioexcitatory neurotransmitter in molluscs, were tested on the ventricle of the bivalve Mercenaria mercenaria. Both agents increased myocardial contractility, the intracellular cyclic AMP concentration of intact hearts and the adenylate cyclase activity of a myocardial membrane fraction. FMRFamide was 5-10 times more potent than 5HT. All of the effects of 5HT, and none of those of FMRFamide, were blocked by methysergide, a specific 5HT antagonist.

KW - 5-Hydroxytryptamine

KW - Adenylate cyclase

KW - Cyclic AMP in muscle

KW - FMRFamide

KW - Methysergide

KW - Molluscan heart

UR - http://www.scopus.com/inward/record.url?scp=0018256749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018256749&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(78)90170-X

DO - 10.1016/0014-2999(78)90170-X

M3 - Article

C2 - 206451

AN - SCOPUS:0018256749

VL - 48

SP - 425

EP - 430

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 4

ER -